Australian CRO Avance Clinical said that Australia’s fast regulatory approval environment, key opinion leader expertise and high-quality clinical research sites, as well as the attractive 40% Government rebate on clinical trial spend, means Avance is uniquely positioned to deliver rapid results for urgent COVID-19
More
Leading Australian CRO Avance Clinical said there was still strong demand from
Leading Australian CRO Avance Clinical said there was still strong demand from Asian and US sponsors, and commended Australian sites
More
Australian CRO Avance Clinical said that Australia’s fast regulatory approval environment, key opinion leader expertise and high-quality clinical research sites,
More
